Contact – +1-276-477-5910
 Email – info@supplydemandmarketresearch.com

Home >>

Healthcare

>>

Asia Pacific Digital Respiratory Solutions Market


Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Report code: SDMRHE1356176 | Industry: Healthcare | Published On: 44040


Asia Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of $219.0 million over 2020-2030 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
Highlighted with 31 tables and 42 figures, this 104-page report “Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Therapeutic Devices
• Inhalers
• Nebulizers
Diagnostic Devices
• Spirometers
• Asthma Monitors
• Other Diagnostic Devices
Sensors and Apps

Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• COVID-19 Caused Diseases
• Other Diseases

Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
3M Health Care Limited
Adherium Limited
Amiko Digital Health Limited
AsthmaMD
AstraZeneca plc
Boehringer Ingelheim International GmbH
Capsule Technologies, Inc.
Cohero Health
GlaxoSmithKline plc
Kaia Health Software GmbH
Medical International Research (MIR)
Novartis AG
NuvoAir
Reciprocal Labs (Propeller Health)
Sensiron AG
Tactio Health
Teva Pharmaceuticals Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

1  Introduction  5
1.1  Industry  Definition  and  Research  Scope  5
1.1.1  Industry  Definition  5
1.1.2  Research  Scope  6
1.2  Research  Methodology  9
1.2.1  Overview  of  Market  Research  Methodology  9
1.2.2  Market  Assumption  10
1.2.3  Secondary  Data  10
1.2.4  Primary  Data  10
1.2.5  Data  Filtration  and  Model  Design  12
1.2.6  Market  Size/Share  Estimation  13
1.2.7  Research  Limitations  14
1.3  Executive  Summary  15
2  Market  Overview  and  Dynamics  17
2.1  Market  Size  and  Forecast  17
2.1.1  Impact  of  COVID-19  on  the  Market  18
2.2  Major  Growth  Drivers  20
2.3  Market  Restraints  and  Challenges  25
2.4  Emerging  Opportunities  and  Market  Trends  28
2.5  Porter’s  Fiver  Forces  Analysis  32
3  Segmentation  of  Asia  Pacific  Market  by  Product  Type  37
3.1  Market  Overview  by  Product  Type  37
3.2  Therapeutic  Devices  39
3.2.1  Inhalers  40
3.2.2  Nebulizers  41
3.3  Diagnostic  Devices  42
3.3.1  Spirometers  44
3.3.2  Asthma  Monitors  45
3.3.3  Other  Diagnostic  Devices  46
3.4  Sensors  and  Apps  47
4  Segmentation  of  Asia  Pacific  Market  by  Indication  48
4.1  Market  Overview  by  Indication  48
4.2  Asthma  50
4.3  Chronic  Obstructive  Pulmonary  Disease  (COPD)  51
4.4  COVID-19  Caused  Diseases  52
4.5  Other  Diseases  53
5  Segmentation  of  Asia  Pacific  Market  by  Distribution  Channel  54
5.1  Market  Overview  by  Distribution  Channel  54
5.2  Hospital  Pharmacies  56
5.3  Retail  Pharmacies  57
5.4  Online  Pharmacies  58
6  Asia-Pacific  Market  2019-2030  by  Country  59
6.1  Overview  of  Asia-Pacific  Market  59
6.2  Japan  62
6.3  China  65
6.4  Australia  68
6.5  India  70
6.6  South  Korea  72
6.7  Rest  of  APAC  Region  74
7  Competitive  Landscape  76
7.1  Overview  of  Key  Vendors  76
7.2  New  Product  Launch,  Partnership,  Investment,  and  M&A  79
7.3  Company  Profiles  80
3M  Health  Care  Limited  80
Adherium  Limited  82
Amiko  Digital  Health  Limited  83
AsthmaMD  84
AstraZeneca  plc  85
Boehringer  Ingelheim  International  GmbH  86
Capsule  Technologies,  Inc.  87
Cohero  Health  88
GlaxoSmithKline  plc  89
Kaia  Health  Software  GmbH  90
Medical  International  Research  (MIR)  91
Novartis  AG  92
NuvoAir  93
Reciprocal  Labs  (Propeller  Health)  94
Sensiron  AG  95
Tactio  Health  96
Teva  Pharmaceuticals  Industries  Ltd.  97
8  Investing  in  Asia  Pacific  Market:  Risk  Assessment  and  Management  98
8.1  Risk  Evaluation  of  Asia  Pacific  Market  98
8.2  Critical  Success  Factors  (CSFs)  101
Related  Reports  and  Products  104
Table 1. Snapshot of Asia Pacific Digital Respiratory Solutions Market, 2019-2030 16
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Digital Respiratory Solutions Market 28
Table 3. Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 37
Table 4. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 39
Table 5. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 43
Table 6. Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 48
Table 7. Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 54
Table 8. APAC Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 60
Table 9. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 64
Table 10. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 64
Table 11. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 64
Table 12. China Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 67
Table 13. China Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 67
Table 14. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 67
Table 15. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 69
Table 16. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 69
Table 17. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 69
Table 18. India Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 71
Table 19. India Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 71
Table 20. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 71
Table 21. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 73
Table 22. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 73
Table 23. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 73
Table 24. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, $ mn 75
Table 25. 3M Health Care Limited: Company Snapshot 80
Table 26. 3M Health Care Limited: Business Segmentation 80
Table 27. 3M Health Care Limited: Product Portfolio 81
Table 28. 3M Health Care Limited: Revenue, 2016-2018, $ mn 81
Table 29. 3M Health Care Limited: Recent Developments 81
Table 30. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 99
Table 31. Critical Success Factors and Key Takeaways 102
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT